Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling

LI Xinhua, YAN Aili, CHANG Jinrui, LI Fen, ZHU Juanxia

Abstract

To investigate whether hesperetin (Hes) alleviates doxorubicin (DOX)-induced cardiomyocytotoxicity by reducing oxidative stress via regulating silent information regulator 1 (SIRT1)/nuclear transcription factor E2-related factor 2 (NRF2) signaling in H9c2 cells.  Methods  H9c2 cells were treated with DOX to establish the cardiotoxicity model and were randomly assigned to four groups, a control group (Control) and three treatment groups, receiving respectively DOX (the DOX group), Hes+DOX (the DOX+Hes group), and Hes+SIRT1 inhibitor EX527+DOX (the DOX+Hes+EX527 group). Cellular morphology was observed by the light microscope. Cell viability was evaluated by CCK-8. DOX-induced apoptosis in H9c2 cells was examined by flow cytometry. The levels of reactive oxygen species (ROS) in the H9c2 cells of the four groups were determied with 2'-7'-dichlorodihydrofluorescein diacetate (DCFH-DA) staining. The activities of lactate dehydrogenase (LDH), superoxide dismutase (SOD), catalase (CAT), and SIRT1 as well as the malondialdehyde (MDA) content were measured using ELISA kits. The expressions of cleaved caspase-3, cytochrome c, SIRT1, Ac-FOXO1, NRF2, and heme oxygenase 1 (HO-1) were determined by Western blot.  Results  Compared with the Control group, the DOX group showed swollen cellular morphology, decreased cell density and viability, and increased LDH activity in the medium (P<0.01); both apoptosis and the expression of cleaved caspase-3 and cytochrome c increased (P<0.01); the activities of CAT and SOD decreased while the contents of MDA and ROS increased (P<0.01); the expression of SIRT1, NRF2, and HO-1 decreased, the activity of SIRT1 decreased, and the expression of Ac-FOXO1 increased (P<0.01). Compared with the DOX group, the DOX+Hes group showed improved cellular morphology, increased cell density and viability, and decreased LDH activity in the medium (P<0.01); the apoptosis and the expression of cleaved caspase-3 and cytochrome c decreased (P<0.01); the activities of CAT and SOD increased while the levels of MDA and ROS decreased (P<0.01); the expression of SIRT1, NRF2, and HO-1 increased, the activity of SIRT1 increased, and the expression of Ac-FOXO1 decreased (P<0.01). Comparison of the findings for the DOX+Hes group and the DOX+Hes+EX527 group showed that EX527 could block the protective effects of Hes against DOX-induced cell injury, oxidative stress, and SIRT1/NRF2 signaling.  Conclusion  Hes inhibits oxidative stress and apoptosis via regulating SIRT1/NRF2 signaling, thereby reducing DOX-induced cardiotoxicity in H9c2 cells.


Keywords: Hesperetin, Oxidative stress, SIRT1/NRF2, H9c2 cells, Doxorubicin

  •  
 

Full Text:

PDF


References


KARLSTAEDT A， MOSLEHI J， De BOER R A. Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer. Nat Rev Cardiol，2022，19(6): 414–425. doi: 10.1038/s41569-022-00698-6.

SHANBHAG S， AMBINDERR F. Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin，2018，68(2): 116–132. doi: 10.3322/caac.21438.

LI Y， LIN R， PENG X， et al. The role of mitochondrial quality control in anthracycline-induced cardiotoxicity: from bench to bedside. Oxid Med Cell Longev，2022，2022: 3659278. doi: 10.1155/2022/3659278.

EFENTAKIS P， VARELA A， CHAVDOULA E， et al. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy. Cardiovasc Res，2020， 116(3): 576–591. doi: 10.1093/cvr/cvz163.

WENNINGMANN N， KNAPP M， ANDE A， et al. Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring. Mol Pharmacol，2019，96(2): 219–232.

KONG C Y， GUO Z， SONG P， et al. Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death. Int J Biol Sci，2022，18(2): 760–770. doi: 10.7150/ijbs.65258.

KAVIYARASI R， ABILASH V G， TIRUPATHI PICHIAH P B， et al. Molecular mechanism of doxorubicin-induced cardiomyopathy--an update. Eur J Pharmacol，2018，818: 241–253. doi: 10.1016/j.ejphar.2017. 10.043.

ROOHBAKHSH A， PARHIZ H， SOLTANI F， et al. Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci，2015，124: 64–74. doi: 10.1016/j.lfs.2014.12.030.

CHEN X， WEI W， LI Y， et al. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chem Biol Interact，2019，308: 269–278. doi: 10.1016/j.cbi. 2019.05.040.

LIU P， LI J， LIU M， et al. Hesperetin modulates the Sirt1/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis. Biomed Pharmacother， 2021，139: 111552. doi: 10.1016/j.biopha.2021.111552.

PARHIZ H， ROOHBAKHSH A， SOLTANI F， et al. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res，2015，29(3): 323–331. doi: 10.1002/ptr.5256.

HE S， WANG X， ZHONG Y， et al. Hesperetin post-treatment prevents rat cardiomyocytes from hypoxia/reoxygenation injury in vitro via activating PI3K/Akt signaling pathway. Biomed Pharmacother，2017，91: 1106–1112. doi: 10.1016/j.biopha.2017.05.003.

SINGH V， UBAID S. Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation，2020，43(5): 1589–1598. doi: 10.1007/s10753-020-01242-9.

XU Y， ZHANG Y， LIANG H， et al. Coumestrol mitigates retinal cell inflammation, apoptosis, and oxidative stress in a rat model of diabetic retinopathy via activation of SIRT1. Aging (Albany NY)，2021，13(4): 5342–5357. doi: 10.18632/aging.202467.

KASAI S， SHIMIZU S， TATARA Y， et al. Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules，2020，10(2): 320. doi: 10.3390/biom10020320.

CADENAS S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med，2018，117: 76–89. doi: 10.1016/j.freeradbiomed.2018.01.024.

LIU D， MA Z， DI S， et al. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radic Biol Med，2018，129: 59–72. doi: 10.1016/j.freeradbiomed.2018.08.032.


Refbacks

  • There are currently no refbacks.